Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06550024Active, not recruiting
Randomised, open-label trial in osteoarthritis (OA) (2 arms), sponsored by CrannMed. Primary endpoints: Proportion of Responders at 6 months and Freedom from treatment-related SAEs at 6 months. Started Nov 2024; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06550024.